MAIA Biotechnology | Investor Presentation Deck | 35 slides · page 4 of 35
The slide outlines clinical trial progress (THIO-101, 102, 103), regulatory designations, and intellectual property status.
Pitch deck · executive_summary · summarize · balanced density
Slide locked Sign in to view
Slide schematic 3/3
image 1/1 list 1/1 title 1/1
Components 3
photo bullet headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.